Scholar Rock Holding (SRRK) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.43% |
| Dec 31, 2025 | 0.20% |
| Sep 30, 2025 | 5.02% |
| Jun 30, 2025 | -25.31% |
| Mar 31, 2025 | -15.27% |
| Dec 31, 2024 | 365.47% |
| Sep 30, 2024 | -40.73% |
| Jun 30, 2024 | -26.89% |
| Mar 31, 2024 | -18.85% |
| Dec 31, 2023 | 34.33% |
| Sep 30, 2023 | -17.20% |
| Jun 30, 2023 | -11.44% |
| Mar 31, 2023 | -12.14% |
| Dec 31, 2022 | -11.26% |
| Sep 30, 2022 | -11.00% |
| Jun 30, 2022 | 92.34% |
| Mar 31, 2022 | -0.44% |
| Dec 31, 2021 | -8.11% |
| Sep 30, 2021 | -13.57% |
| Jun 30, 2021 | -9.93% |
| Mar 31, 2021 | -7.76% |
| Dec 31, 2020 | 314.07% |
| Sep 30, 2020 | -23.36% |
| Jun 30, 2020 | -16.70% |
| Mar 31, 2020 | -12.63% |
| Dec 31, 2019 | -7.30% |
| Sep 30, 2019 | -5.56% |
| Jun 30, 2019 | 32.23% |
| Mar 31, 2019 | -8.53% |
| Dec 31, 2018 | 4.18% |
| Sep 30, 2018 | -8.30% |
| Jun 30, 2018 | 280.22% |
| Mar 31, 2018 | -15.71% |